John Shufeldt Net Worth 2025: Philanthropreneur’s $150M Empire

Who Is John Shufeldt?

John Shufeldt, MD, JD, MBA, FACEP, is a multidisciplinary entrepreneur whose career spans emergency medicine, legal advocacy, business strategy, and philanthropy. With over three decades of experience, he has become a pivotal figure in healthcare innovation, blending clinical expertise with entrepreneurial acumen.

A graduate of Drake University (BA in Sociology and Criminology), the Rosalind Franklin University of Medicine and Science, and Arizona State University (JD, MBA, Six Sigma Black Belt), Shuf fieldt holds certifications from Harvard Business School (Entrepreneurism and Innovation) and MIT (AI). His academic rigor is matched by his professional versatility: he is a board-certified emergency physician, a venture capitalist, and a published author.

Shufeldt’s work is defined by a dual mission: to democratize healthcare access and to leverage technology for systemic efficiency. His ventures, such as NextCare Urgent Care and MeMD, have redefined urgent care and telehealth, while his investments in Xcellerant Ventures continue to fuel healthtech innovation. Beyond business, his philanthropy—most notably the $100M+ ASU medical school donation—reflects a commitment to long-term societal impact.

How He Built a $150M Net Worth

Shufeldt’s wealth is the result of strategic, high-impact ventures and exits. His entrepreneurial journey began in the 1990s, when he co-founded NextCare Urgent Care, a network that disrupted traditional urgent care models by prioritizing accessibility and efficiency. By 2025, NextCare had grown to 60+ clinics across multiple states, generating $100M+ in annual revenue before its acquisition by a private equity group. The network’s success was driven by its ability to fill gaps in primary care, offering extended hours and walk-in services at lower costs.

In 2021, Shufeldt’s MeMD—a telemedicine platform—was acquired by Walmart for a 10x MOIC (multiple on invested capital). MeMD’s value lay in its ability to scale virtual consultations, a critical need during the pandemic. Walmart integrated MeMD into its healthcare ecosystem, leveraging Shufeldt’s platform to expand telehealth access to millions of customers. This exit not only solidified Shufeldt’s reputation as a telehealth pioneer but also underscored the market potential of remote care solutions.

Equally notable is StatRead, an early tele-radiology company Shufeldt founded in the 2000s. By automating radiology reports and enabling remote diagnostics, StatRead addressed a critical bottleneck in hospital workflows. Its exit in the mid-2010s yielded a 50x MOIC, one of the highest returns in healthcare tech history. This success highlights Shufeldt’s ability to identify underserved niches and scale them into industry leaders.

His ventures are supported by Xcellerant Ventures, the venture capital firm he co-founded in 2010. As a general partner, Shufeldt invests in early-stage healthtech and medtech startups, focusing on AI-driven diagnostics, wearable health monitors, and decentralized care platforms. His dual role as entrepreneur and investor ensures a continuous pipeline of innovation, further diversifying his wealth.

Income Streams and Exit Strategies

Shufeldt’s income is derived from three core sources: active businesses, investment returns, and philanthropy.

1. Business Revenue: NextCare and other operational ventures contribute $8–10 million annually. These businesses benefit from recurring revenue models, such as clinic memberships and telehealth subscription plans.

2. Investment Returns: High-impact exits like MeMD (10x MOIC) and StatRead (50x MOIC) have provided significant liquidity. For example, the StatRead exit alone likely generated $50M+ for Shufeldt and his investors, a testament to his ability to scale niche technologies.

3. Philanthropy: The $100M+ ASU medical school donation reflects his commitment to reinvesting profits into education. This donation not only funds infrastructure but also supports scholarships for underrepresented students, ensuring equitable access to medical training.

Shufeldt’s income varies yearly due to the cyclical nature of business growth and market conditions. For instance, the 2025 ASU donation likely reduced his liquid assets but amplified his long-term impact. This balance between profit and purpose is a hallmark of his career.

Philanthropy: The $100M+ ASU Medical School Gift

In 2025, Shufeldt made headlines with a $100 million+ naming gift to Arizona State University, establishing the John Shufeldt School of Medicine and Medical Engineering. This donation, the largest in ASU’s history, is not merely a financial transaction but a strategic investment in the future of healthcare.

The school’s curriculum integrates AI-driven diagnostics, telehealth, and interdisciplinary collaboration, reflecting Shufeldt’s own career. For example, students will learn to develop AI algorithms for radiology, a direct application of StatRead’s legacy. Additionally, the school prioritizes cost-effective care models, such as urgent care and virtual consultations, which align with NextCare’s and MeMD’s missions.

Beyond infrastructure, the donation funds scholarships for underrepresented groups, addressing systemic barriers in medical education. Shufeldt’s rationale is clear: “Healthcare innovation must be inclusive. If we don’t train diverse minds, we’ll miss opportunities to solve complex problems.” This vision is already materializing, with ASU’s first cohort of Shufeldt Scholars set to graduate in 2027.

10 Key Facts About John Shufeldt Net Worth

1. Net Worth Estimate

As of 2025, Shufeldt’s net worth is approximately $150 million, according to GenshinQuotes and industry reports. This figure includes active businesses, investments, and the ASU donation.

2. NextCare’s Growth

NextCare expanded to 60+ clinics and generated $100M+ in revenue before its acquisition. The network’s success was driven by its ability to provide affordable, high-quality urgent care.

3. MeMD’s Walmart Acquisition

MeMD, a telemedicine company, was acquired by Walmart in 2021 for a 10x MOIC. The deal expanded Walmart’s telehealth offerings, aligning with Shufeldt’s vision for accessible care.

4. StatRead Exit

StatRead, an early tele-radiology company, was sold for a 50x MOIC, one of the highest returns in healthcare tech.

5. ASU Medical School Donation

Shufeldt donated $100M+ to ASU, naming its new medical school and funding AI and telehealth programs.

6. Annual Income

His annual income ranges between $8–10 million, varying with business performance and investments.

7. Education Background

Shufeldt holds an MD from Rosalind Franklin University, a JD and MBA from Arizona State, and certificates from Harvard and MIT.

8. Venture Capital Role

As a general partner at Xcellerant Ventures, he invests in early-stage healthtech and medtech startups.

9. Social Media Presence

He maintains a limited personal social media profile but is active on professional networks like LinkedIn.

10. Entrepreneurial Legacy

Shufeldt has founded 5+ healthcare startups, including EmPower (a multi-hospital emergency medicine group) and USCareways.

FAQ: Common Questions About John Shufeldt Net Worth

1. What Is John Shufeldt’s Primary Source of Wealth?

Shufeldt’s wealth comes from healthcare startups like NextCare and MeMD, high-impact exits (e.g., StatRead’s 50x MOIC), and investments. His annual income ranges from $8–10 million.

2. How Did He Sell MeMD to Walmart?

MeMD, a telemedicine platform, was acquired by Walmart in 2021 for a 10x MOIC. The deal expanded Walmart’s telehealth offerings, aligning with Shufeldt’s vision for accessible care.

3. Why Did He Donate $100M+ to ASU?

The donation funds the John Shufeldt School of Medicine and Medical Engineering, advancing AI-driven diagnostics and telehealth education. It reflects his commitment to merging innovation with healthcare accessibility.

4. What Are His Most Profitable Ventures?

StatRead (50x MOIC exit) and MeMD (10x MOIC) are his most lucrative ventures. NextCare, now a $100M+ urgent care network, remains a core revenue driver.

5. How Does His Medical Background Influence His Business?

Shufeldt’s emergency medicine expertise informs his focus on efficiency, patient care, and tech-driven solutions. His legal and MBA training help him navigate regulatory and financial challenges.

6. What Role Does He Play at Xcellerant Ventures?

As a general partner, Shufeldt leads early-stage investments in healthtech and medtech startups, leveraging his clinical and entrepreneurial experience to identify scalable innovations.

Conclusion: The Philanthropreneur’s Legacy

John Shufeldt’s $150 million net worth is a testament to his ability to blend clinical expertise with entrepreneurial vision. From scaling urgent care networks to pioneering telemedicine, his ventures have reshaped healthcare delivery. Yet his legacy extends beyond wealth: the $100M+ ASU donation ensures future generations benefit from his innovations, proving that business success can drive societal progress.

Shufeldt’s story offers a blueprint for modern healthcare entrepreneurship—prioritizing scalability, efficiency, and accessibility while reinvesting profits into education and innovation. For readers, his journey underscores the power of interdisciplinary thinking and the importance of aligning profit with purpose.